Events Benefits of Non-Viral, Scalable Transfection for Assay Development, Protein Production & Cell Therapy Enablement Seminar

Benefits of Non-Viral, Scalable Transfection for Assay Development, Protein Production & Cell Therapy Enablement Seminar

Join us for a breakfast seminar at Brown University

Wednesday, April 23, 2025

10:00 to 11:00 a.m.

Event details

Location:
Brown University
Sidney Frank Hall, Room 450
185 Meeting St., Providence, RI 02912

Join us for a breakfast seminar hosted by MaxCyte^® and Arturo Andrade, PhD, Associate Professor of Brain Science at Brown University.

This in-person session will explore how MaxCyte’s non-viral transfection platform enables efficient, scalable delivery for a range of applications—from ion channel assays and protein expression to cutting-edge work in cell therapy. Learn how researchers across academia and industry are using this technology to accelerate discovery and translational progress.

Presented by MaxCyte’s Business Development and Field Applications teams, this seminar is ideal for scientists working in neuroscience, assay development or cell therapy who are interested in high-efficiency, clinically validated delivery technologies.

Breakfast will be provided. Space is limited—reserve your seat today!

Speakers

Joseph White

Field Applications Scientist, MaxCyte, Inc.

Joseph is a field applications scientist for MaxCyte dedicated to the southern New England and New York region with over 12 years of cell culture experience. He earned his PhD in biological sciences from the University at Buffalo and completed a postdoctoral fellowship at Duke University, where he researched neurodegeneration using iPSC-derived cells and animal models. Prior to working at MaxCyte, Joseph served as a senior scientist at Thermo Fisher Scientific, where he led new product innovation for bioproduction and cell/gene therapy workflows. Based in Buffalo, New York, Joseph is passionate about the Bills and, more importantly, aiding in the advancement of therapeutic research from lab to clinic.

Jess Keeley

Business Development Manager, MaxCyte, Inc.

Jess holds a degree in biology from the University of Pittsburgh and has built a robust career in biotechnology. With roles at companies such as Thermo Fisher, Biotage and MaxCyte, he has extensively supported both industry and academic research labs in their cell therapy, gene therapy and drug discovery workflows. Currently, Jess serves as a strategic business manager for MaxCyte, overseeing the Northeast US.